Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bundamedik Tbk (BMHS) vs UBC Medical Indonesia Tbk. (LABS)

Bundamedik TbkTrading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bundamedik Tbk dan UBC Medical Indonesia Tbk.: Bundamedik Tbk diperdagangkan di Rp176 (kapitalisasi pasar 1,51 T, volume 24 jam 536,7 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Bundamedik Tbk jauh lebih besar — sekitar 2,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 536,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

BMHSLABS
Kapitalisasi Pasar
1,51 T584,6 M
Volume
536,7 rb817,3 rb
Lot
5,37 rb8,17 rb
Perputaran
93,41 jt120,01 jt
Harga Rata-rata
174,05146,84
Nilai Transaksi
93,41 jt120,01 jt
Harga Ekuilibrium Indikatif
176146
Volume Ekuilibrium Indikatif
10059

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BMHS
Lihat detail
LABS
Lihat detail

Tentang Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Selengkapnya di halaman BMHS

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS